Treating depression and substance use: A randomized controlled trial

Journal of Substance Abuse Treatment

Volumn 43, Issue 2, 2012, Pages 137-151

  Hunter, Sarah B ^a   Watkins, Katherine E ^a   Hepner, Kimberly A ^a   Paddock, Susan M ^a   Ewing, Brett A ^a   Osilla, Karen C ^a   Perry, Suzanne ^a  

^a RAND CORPORATION   (United States)

Author keywords

Addiction; Co occurring disorders; Cognitive behavioral therapy; Depression; Group therapy

Indexed keywords

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; FEASIBILITY STUDY; FEMALE; GROUP THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE;

ADULT; COGNITIVE THERAPY; COUNSELING; DATA COLLECTION; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PATIENT SELECTION; PSYCHIATRIC STATUS RATING SCALES; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84864301259     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2011.12.004     Document Type: Article

References (93)

1. Alcoholics Anonymous Alcoholics Anonymous 2001, Available at. http://www.aa.org/bigbookonline/, 4th ed.
2. American Psychiatric Association Practice guideline for the treatment of patients with substance use disorder 2006, Available at. http://www.psychiatryonline.com/pracGuide/pracGuideTopic_5.aspx, 2nd ed.
3. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder 2010, Available at. http://www.psych.org/guideliness/mdd2010, 3rd ed.
4. Barber J., Liese B., Abrams M. Development of the Cognitive Therapy Adherence and Competence Scale. Psychotherapy Research 2003, 13:205-221.
5. Beck A., Steer R., Brown G. BDI-II, Beck Depression Inventory: Manual 1996, Harcourt Brace, Boston, MA. 2nd ed.
6. Beck A.T., Steer R.A., Garbin M.G. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review 1988, 8:77-100.
7. Berger V.W., Exner D.V. Detecting selection bias in randomized clinical trials. Clinical Trials 1999, 20:319-327.
8. Blanchard K.A., Morgenstern J., Morgan T.J., Lobouvie E.W., Bux D.A. Assessing consequences of substance use: Psychometric properties of the inventory of drug use consequences. Psychology of Addictive Behaviors 2003, 17:328-331.
9. Brown R.A., Evans D.M., Miller I.W., Burgess E.S., Mueller T.I. Cognitive-behavioral treatment for depression in alcoholism. Journal of Consulting and Clinical Psychology 1997, 65:715-726.
10. Brown S.A., Schuckit M.A. Changes in depression among abstinent alcoholics. Journal of Studies on Alcohol 1988, 49:412-417.
11. Browne W.J., Goldstein H., Rasbash J. Multiple Membership Multiple Classification (MMMC) models. Statistical Modeling 2001, 1:103-124.
12. Buckley T., Parker J., Heggie J. A psychometric evaluation of the BDI-II in treatment-seeking substance abusers. Journal of Substance Abuse Treatment 2001, 20:197-204.
13. Burnam M.A., Watkins K.E. Substance abuse with mental disorders: Specialized public systems and integrated care. Health Affairs (Millwood) 2006, 25:648-658.
14. Byrt T., Bishop J., Carlin J. Bias, prevalence and kappa. Journal of Clinical Epidemiology 1993, 46:423-429.
15. Carey K. A multilevel modeling approach to analysis of patient costs under managed care. Health Economics 2000, 9:435-446.
16. Carroll K.M., Ball S.A., Martino S., Nich C., Babuscio T.A., Nuro K.F., et al. Computer-assisted delivery of cognitive-behavioral therapy for addiction: A randomized trial of CBT4CBT. American Journal of Psychiatry 2008, 165:881-888.
17. Charney D.A., Paraherakis A.M., Gill K.J. Integrated treatment of comorbid depression and substance use disorders. Journal of Clinical Psychiatry 2001, 62:672-677.
18. Clark R.E., Samnaliev M., McGovern M.P. Impact of substance disorders on medical expenditures for Medicaid beneficiaries with behavioral health disorders. Psychiatric Services 2009, 60:35-42.
19. Cleary M., Hunt G.E., Matheson S.L., Siegfried N., Walter G. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews 2008, 1:1-29. (CD001088).
20. Cocco K., Carey K. Psychometric properties of the Drug Abuse Screening Test in psychiatric outpatients. Psychological Assessment 1998, 10:408-414.
21. Compton W.M., Thomas Y.F., Stinson F.S., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 2007, 64:566-576.
22. Conrod P.J., Stewart S.H. A critical look at dual-focused cognitive-behavioral treatments for comorbid substance use and psychiatric disorders: Strengths, limitations, and future directions. Journal of Cognitive Psychotherapy: An International Quarterly 2005, 19:265-289.
23. Cuijpers P., Muñoz R.F., Clarke G.N., Lewinsohn P.M. Psychoeducational treatment and prevention of depression: The "Coping with Depression" course thirty years later. Clinical Psychology Review 2009, 29:449-458.
24. Curran G.M., Flynn H.A., Kirchner J.E., Booth B.M. Depression after alcohol treatment as a risk factor for relapse. Journal of Substance Abuse Treatment 2000, 19:259-265.
25. Dawson D.A., Grant B.F., Stinson F.S., Zhou Y. Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcoholism. Clinical and Experimental Research 2005, 29:844-854.
26. Dennis M.L., White M., Titus J.C., Unsicker J. Short Blessed Scale Exam. Global appraisal of individual needs: Trainer's training manual and resources (July 2006 version) 2006, Chestnut Health Systems, Bloomington, IL.
27. Dickey B., Azeni H. Persons with dual diagnoses of substance abuse and major mental illness: Their excess costs of psychiatric care. American Journal of Public Health 1996, 86:973-977.
28. Drake R.E., Essock S.M., Shaner A., Carey K.B., Minkoff K., Kola L., et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services 2001, 52:469-476.
29. Ducharme L.J., Knudsen H.K., Roman P.M. Availability of integrated care for co-occurring substance abuse and psychiatric conditions. Community Mental Health Journal 2006, 42:363-375.
30. Fitzmaurice G., Laird N.M., Ware J. Applied longitudinal analysis 2004, John Wiley & Sons, Hoboken, NJ.
31. Flynn P.M., Brown B.S. Co-occurring disorders in substance abuse treatment: Issues and prospects. Journal of Substance Abuse Treatment 2008, 34:36-47.
32. Gilman S.E., Abraham H.D. A longitudinal study of the order of onset of alcohol dependence and major depression. Drug and Alcohol Dependence 2001, 63:277-286.
33. Haro J.M., Arbabzadeh-Bouchez S., Brugha T.S., de Girolamo G., Guyer M.E., Jin R., et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys. International Journal of Methods in Psychiatric Research 2006, 15:167-180.
34. Harris K.M., Edlund M.J. Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatric Services 2005, 56:954-959.
35. Hasin D., Liu X., Nunes E., McCloud S., Samet S., Endicott J. Effects of major depression on remission and relapse of substance dependence. Archives of General Psychiatry 2002, 59:375-380.
36. Havassy B.E., Alvidrez J., Mericle A.A. Disparities in use of mental health and substance abuse services by persons with co-occurring disorders. Psychiatric Services 2009, 60:217-223.
37. Hawks R., Chiang C. Urine testing for drugs of abuse (National Institute for Druge Abuse (NIDA), Research Monograph, 73) 1986, Available at. http://archives.drugabuse.gov/pdf/monographs/download73.html.
38. Hepner K.A., Hunter S.B., Edelen M.O., Zhou A.J., Watkins K.E. A comparison of two depressive symptomology measures in residential substance abuse treatment clients. Journal of Substance Abuse Treatment 2009, 37:318-325. PMCID2762442.
39. Hepner K.A., Miranda J.M., Woo S.M., Watkins K.E., Lagomasino I.T., Wiseman S.H., et al. BRIGHT: A group cognitive behavioral therapy for depression in clients with co-occurring alcohol and drug use problems 2011, RAND Corporation, Santa Monica, CA.
40. Hepner K.A., Muñoz R.F., Woo S.M., Osilla K.C., Wiseman S.H., Watkins K.E. BRIGHT-2: A group cognitive behavioral therapy for co-occurring depression and alcohol and drug use problems 2011, RAND Corporation, Santa Monica, CA.
41. Hepner K.A., Stern S., Paddock S.M., Hunter S.B., Osilla K.C., Watkins K.E. A fidelity coding guide for a group cognitive behavioral therapy for depression (TR-980-NIDA/NIAAA) 2011, RAND Corporation, Santa Monica, CA, Available at. http://www.rand.org/pubs/technical_reports/TR980.html.
42. Hesse M. Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry 2009, 9:6.
43. Hoff R.A., Rosenheck R.A. Long-term patterns of service use and cost among patients with both psychiatric and substance abuse disorders. Medical Care 1998, 36:835-843.
44. Horsfall J., Cleary M., Hunt G.E., Walter G. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): A review of empirical evidence. Harvard Review of Psychiatry 2009, 17:24-34.
45. Hser Y.I., Evans E., Huang D., Anglin D.M. Relationship between drug treatment services, retention, and outcomes. Psychiatric Services 2004, 55:767-774.
46. Hughes J.R., Rose G.L., Callas P.W. Nicotine is more reinforcing in smokers with a past history of alcoholism than in smokers without this history. Alcoholism: Clinical and Experimental Research 2000, 24:1633-1638.
47. Husband S.D., Marlowe D.B., Lamb R.J., Iguchi M.Y., Bux D.A., Kirby K.C., et al. Decline in self-reported dysphoria after treatment entry in inner-city cocaine addicts. Journal of Consulting and Clinical Psychology 1996, 64:221-224.
48. Jaycox L.H., Langley A.K., Stein B.D., Wong M., Sharma P., Schonlau M. Support for students exposed to trauma: A pilot study. School Mental Health 2009, 1:49-60.
49. Johnson J., Burlingame G., Olsen J., Davies D., Gleave R. Group climate, cohesion, alliance, and empathy in group psychotherapy multilevel structural equation models. Journal of Counseling Psychology 2005, 52:310-321.
50. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., Leaf P.J. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry 1996, 66:17-31.
51. Kessler R.C., Ustun T.B. The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research 2004, 13:93-121.
52. Kodl M.M., Fu S.S., Willenbring M.L., Gravely A., Nelson D.B., Joseph A., et al. The impact of depressive symptoms on alcohol and cigarette consumption following treatment for alcohol and nicotine dependence. Alcoholism: Clinical and Experimental Research 2008, 32.
53. Kraemer H.C., Mintz J., Noda A., Tinklenberg J., Yesavage J.A. Caution regarding the use of pilot studies to guide power calculations for study proposals. Archives of General Psychiatry 2006, 63:484-489.
54. Lambert M.J., Davis M.J. Treatment for depression: What the research says. Comparative treatments of depression 2002, 21-46. Springer, New York. M.A. Reinecke, M.R. Davison (Eds.).
55. Landis J., Koch G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
56. Lewinsohn P.M., Antonuccio D.O., Steinmetz-Breckenridge J.L., Teri L. The Coping with Depression course: A psychoeducational intervention for unipolar depression 1984, Castalia Publishing, Eugene, OR.
57. Little R.J.A. Missing data adjustments in large surveys. Journal of Business and Economic Statistics 1988, 6:287-296.
58. Maisto S.A., Carey M.P., Carey K.B., Gordon C.M., Gleason J.R. Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychological Assessment 2000, 12:186-192.
59. Marlatt G.A., Gordon J.R. Determinants of relapse: Implications for the maintenance of behavior change. Behavioral medicine: Changing health lifestyles 1980, 1410-1452. Brunner/Mazel, New York. P. Davidson, S.M. Davidson (Eds.).
60. Marlatt G.A., Gordon J.R. Relapse prevention: Maintenance strategies in the treatment of addictive behaviors 1985, Guilford Press, New York.
61. Relapse prevention: Maintenance strategies in addictive behavior change 2005, Guilford Press, New York. 2nd ed. G.A. Marlatt, D.M. Donovan (Eds.).
62. McGovern M.P., Xie H., Segal S.R., Siembab L., Drake R.E. Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers. Journal of Substance Abuse Treatment 2006, 31:267-275.
63. McLellan A.T., Carise D., Coyne T.H. Addiction Severity Index (ASI) 2005, Treatment Research Institute. 5th ed.
64. Montgomery E.C., Kunik M.E., Wilson N., Stanley M.A., Weiss B. Can paraprofessionals deliver cognitive-behavioral therapy to treat anxiety and depressive symptoms?. Bulletin of the Menninger Clinic 2010, 74:45-62.
65. Morgenstern J., Morgan T., McCrady B., Keller D., Carroll K. Manual-guided cognitive-behavioral therapy training: A promising method for disseminating empirically supported substance abuse treatments to the practice community. Psychology of Addictive Behaviors 2001, 15:83-88.
66. Mueser K.T., Noordsy D.L., Drake R.E., Fox L. Integrated treatment for dual disorders: A guide to effective practice 2003, Guilford Press, New York.
67. Muñoz R., Ippen C., Rao S., Le H., Dwyer E. Manual for group cognitive-behavioral therapy of major depression: A reality management approach. San Francisco: Cognitive Behavioral Depression Clinic, San Francisco General Hospital, University of California, San Francisco 2000.
68. Osilla K.C., Hepner K.A., Munoz R.F., Woo S., Watkins K. Developing an integrated treatment for substance use and depression using cognitive-behavioral therapy. Journal of Substance Abuse Treatment 2009, 37:412-420.
69. Perepletchikova F., Kazdin A.E. Treatment integrity and therapeutic change: Issues and research recommendations. Clinical Psychology: Science and Practice 2005, 12:365-383.
70. Petry N.M. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug and Alcohol Dependence 2000, 58:9-25.
71. Pettinati H.M., Oslin D.W., Kampman K.M., Dundon W.D., Xie H., Gallis T.L., et al. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. American Journal of Psychiatry 2010, 167:620-622.
72. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction 2006, 101:1546-1560.
73. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol 1997, 58:7-29. Project MATCH Research Group.
74. Rapaport M.H., Judd L.L., Schettler P.J., Yonkers K.A., Thase M.E., Kupfer D.J., et al. A descriptive analysis of minor depression. American Journal of Psychiatry 2002, 159:637-643.
75. Rawson R.A., Shoptaw S.J., Obert J.L., McCann M.J., Hasson A.L., Marinelli-Casey P.J., et al. An intensive outpatient approach for cocaine abuse treatment: The matrix model. Journal of Substance Abuse Treatment 1995, 12:117-127.
76. Rounsaville B.J., Carroll K.M., Onken L.S. A stage model of behavioral therapies research: Getting started and moving on from Stage 1. Clinical Psychology: Science and Practice 2001, 8:133-142.
77. SAS Institute Inc SAS/Stat 9.2 user's guide 2008, SAS Institute Inc, Cary, NC.
78. Sholomskas D.E., Syracuse-Siewert G., Rounsaville B.J., Nuro K.F., Carroll K.M. Train in vain: A dissemination trial of three strategies of raining clinicians in cognitive behavioral therapy. Journal of Consulting and Clinical Psychology 2005, 73:106-115.
79. Skinner H.A. The Drug Abuse Screening Test. Addictive Behaviors 1982, 7:363-371.
80. Sloan K., Kivlahan D., Saxon A. Detecting bipolar disorder among treatment-seeking substance abusers. American Journal of Drug and Alcohol Abuse 2000, 26:13-23.
81. Sobell L.C., Sobell M.B. Timeline followback: A technique for assessing self-reported ethanol consumption. Measuring alcohol consumption: Psychosocial and biological methods 1992, 41-72. Humana Press, Totowa, NJ. J. Allen, R.Z. Litten (Eds.).
82. Strain E.C., Stitzer M.L., Bigelow G.E. Early treatment time course of depressive symptoms in opiate addicts. Journal of Nervous and Mental Disease 1991, 179:215-221.
83. Substance Abuse and Mental Health Services Administration National Survey of Substance Abuse Treatment Services (N-SSATS) 2006, US Department of Health and Human Services, Washington, DC.
84. Substance Abuse and Mental Health Services Administration Results from the 2008 National Survey on Drug Use and Health: National findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434) 2009, Rockville, MD.
85. Substance Abuse and Mental Health Services Administration Integrated treatment for co-occurring disorders (SMA08-4367-09) Available at. http://store.samhsa.gov/shin/content/SMA08-4367/SMA08-4367-09.pdf.
86. Tiet Q.Q., Mausbach B. Treatments for patients with dual diagnosis: A review. Alcoholism: Clinical and Experimental Research 2007, 31:513-536.
87. Tonigan J.S., Miller W.R. The inventory of drug use consequences (InDUC): Test-retest stability and sensitivity to detect change. Psychology of Addictive Behaviors 2002, 16:165-168.
88. Ware J., Kosinski M., Turner-Bowker D., Gandek B. How to score Version 2 of the SF-12® Health Survey (with a supplement documenting version 1) 2002, Quality Metric Incorporated, Lincoln, RI.
89. Watkins K.E., Burnam A., Kung F.Y., Paddock S. A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatric Services 2001, 52:1062-1068.
90. Watkins K.E., Hunter S.B., Burnam M.A., Pincus H.A., Nicholson G. Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder. Psychiatric Services 2005, 56:913-926.
91. Wells K.B., Sturm R., Sherbourne C.D., Meredith L. Caring for depression 1996, Harvard University Press, Cambridge, MA.
92. Wenzel S.L., Ebener P., Hunter S.B., Watkins K.E., Gilmore J.M. Research-practice partners assess their first joint project. NIDA Science and Practice Perspectives 2005, 38-45.
93. Witkiewitz K., Villarroel N.A. Dynamic association between negative affect and alcohol lapses following alcohol treatment. Journal of Consulting and Clinical Psychology 2009, 77:633-644.